All terms in DRUGBANK

Label Id Description
3'-Phosphate-Adenosine-5'-Diphosphate DB01842
Acetyldigitoxin DB00511 [Cardioactive derivative of lanatoside A or of digitoxin used for fast digitalization in congestive heart failure.]
4,6-Dideoxyglucose DB01841
Proxazole DB13819
Doxefazepam DB13837
Fenamole DB12506 [Fenamole has been investigated for the supportive care of Side Effects and Dental Plaque.]
Noxytiolin DB13838 [Local antibacterial that probably acts by releasing formaldehyde in aqueous solutions. It is used for THERAPEUTIC IRRIGATION of infected body cavities - bladder, peritoneum, etc. and as a spray for burns.]
Atecegatran metoxil DB12507 [Atecegatran metoxil has been used in trials studying the basic science and prevention of Nonvalvular Atrial Fibrillation, Persistent or Permanent Nonvalvular Atrial Fibrillation, and Persistent or Permanent Non-valvular Atrial Fibrillation.]
E7107 DB12508 [E7107 has been used in trials studying the treatment of Cancer.]
Dipyrocetyl DB13839
Imeglimin DB12509 [Imeglimin has been used in trials studying the treatment of Type 2 Diabetes Mellitus.]
Methylatropine DB13833
Phenylmercuric borate DB13834
Caroverine DB13835
JNJ-40346527 DB12504 [JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.]
E-7820 DB12505 [E7820 has been investigated for the treatment of Colon Cancer and Rectal Cancer.]
Metampicillin DB13836 [Metampicillin is a penicillin antibiotic prepared by the reaction of ampicillin with formaldehyde. It is hydrolysed in aqueous solution to form ampicillin. Hydrolysis is rapid under acid conditions like the stomach.]
Copper usnate DB13830
Fedratinib DB12500 [Fedratinib, also known as SAR302503 and TG101348, is a tyrosine kinase inhibitor used to treat intermediate-2 and high risk primary and secondary myelofibrosis.[A183176,L8090] It is an anilinopyrimidine derivative.[A183188] Fedratinib was granted FDA approval on August 16, 2019.[L8090]]
Potassium permanganate DB13831